Global Encorafenib Market Growth 2025-2031

December 2025 | 77 pages | ID: GB689F89B4AEN
LP Information

Abstracts

The global Encorafenib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Encorafenib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Encorafenib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Encorafenib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Encorafenib players cover Array BioPharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Encorafenib Industry Forecast” looks at past sales and reviews total world Encorafenib sales in 2024, providing a comprehensive analysis by region and market sector of projected Encorafenib sales for 2025 through 2031. With Encorafenib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encorafenib industry.

This Insight Report provides a comprehensive analysis of the global Encorafenib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encorafenib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Encorafenib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encorafenib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encorafenib.

This report presents a comprehensive overview, market shares, and growth opportunities of Encorafenib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 50mg Capsules
• 75mg Capsules

Segmentation by Application:

• Hospital
• Clinic
• Pharmacy
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Array BioPharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Encorafenib market?

What factors are driving Encorafenib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Encorafenib market opportunities vary by end market size?

How does Encorafenib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Encorafenib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Encorafenib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Encorafenib by Country/Region, 2020, 2024 & 2031
2.2 Encorafenib Segment by Type
  2.2.1 50mg Capsules
  2.2.2 75mg Capsules
2.3 Encorafenib Sales by Type
  2.3.1 Global Encorafenib Sales Market Share by Type (2020-2025)
  2.3.2 Global Encorafenib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Encorafenib Sale Price by Type (2020-2025)
2.4 Encorafenib Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Pharmacy
  2.4.4 Others
2.5 Encorafenib Sales by Application
  2.5.1 Global Encorafenib Sale Market Share by Application (2020-2025)
  2.5.2 Global Encorafenib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Encorafenib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Encorafenib Breakdown Data by Company
  3.1.1 Global Encorafenib Annual Sales by Company (2020-2025)
  3.1.2 Global Encorafenib Sales Market Share by Company (2020-2025)
3.2 Global Encorafenib Annual Revenue by Company (2020-2025)
  3.2.1 Global Encorafenib Revenue by Company (2020-2025)
  3.2.2 Global Encorafenib Revenue Market Share by Company (2020-2025)
3.3 Global Encorafenib Sale Price by Company
3.4 Key Manufacturers Encorafenib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Encorafenib Product Location Distribution
  3.4.2 Players Encorafenib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ENCORAFENIB BY GEOGRAPHIC REGION

4.1 World Historic Encorafenib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Encorafenib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Encorafenib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Encorafenib Market Size by Country/Region (2020-2025)
  4.2.1 Global Encorafenib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Encorafenib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Encorafenib Sales Growth
4.4 APAC Encorafenib Sales Growth
4.5 Europe Encorafenib Sales Growth
4.6 Middle East & Africa Encorafenib Sales Growth

5 AMERICAS

5.1 Americas Encorafenib Sales by Country
  5.1.1 Americas Encorafenib Sales by Country (2020-2025)
  5.1.2 Americas Encorafenib Revenue by Country (2020-2025)
5.2 Americas Encorafenib Sales by Type (2020-2025)
5.3 Americas Encorafenib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Encorafenib Sales by Region
  6.1.1 APAC Encorafenib Sales by Region (2020-2025)
  6.1.2 APAC Encorafenib Revenue by Region (2020-2025)
6.2 APAC Encorafenib Sales by Type (2020-2025)
6.3 APAC Encorafenib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Encorafenib by Country
  7.1.1 Europe Encorafenib Sales by Country (2020-2025)
  7.1.2 Europe Encorafenib Revenue by Country (2020-2025)
7.2 Europe Encorafenib Sales by Type (2020-2025)
7.3 Europe Encorafenib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Encorafenib by Country
  8.1.1 Middle East & Africa Encorafenib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Encorafenib Revenue by Country (2020-2025)
8.2 Middle East & Africa Encorafenib Sales by Type (2020-2025)
8.3 Middle East & Africa Encorafenib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encorafenib
10.3 Manufacturing Process Analysis of Encorafenib
10.4 Industry Chain Structure of Encorafenib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Encorafenib Distributors
11.3 Encorafenib Customer

12 WORLD FORECAST REVIEW FOR ENCORAFENIB BY GEOGRAPHIC REGION

12.1 Global Encorafenib Market Size Forecast by Region
  12.1.1 Global Encorafenib Forecast by Region (2026-2031)
  12.1.2 Global Encorafenib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Encorafenib Forecast by Type (2026-2031)
12.7 Global Encorafenib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Array BioPharma
  13.1.1 Array BioPharma Company Information
  13.1.2 Array BioPharma Encorafenib Product Portfolios and Specifications
  13.1.3 Array BioPharma Encorafenib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Array BioPharma Main Business Overview
  13.1.5 Array BioPharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Encorafenib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Encorafenib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 50mg Capsules
Table 4. Major Players of 75mg Capsules
Table 5. Global Encorafenib Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Encorafenib Sales Market Share by Type (2020-2025)
Table 7. Global Encorafenib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Encorafenib Revenue Market Share by Type (2020-2025)
Table 9. Global Encorafenib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Encorafenib Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Encorafenib Sale Market Share by Application (2020-2025)
Table 12. Global Encorafenib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Encorafenib Revenue Market Share by Application (2020-2025)
Table 14. Global Encorafenib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Encorafenib Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Encorafenib Sales Market Share by Company (2020-2025)
Table 17. Global Encorafenib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Encorafenib Revenue Market Share by Company (2020-2025)
Table 19. Global Encorafenib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Encorafenib Producing Area Distribution and Sales Area
Table 21. Players Encorafenib Products Offered
Table 22. Encorafenib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Encorafenib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Encorafenib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Encorafenib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Encorafenib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Encorafenib Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Encorafenib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Encorafenib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Encorafenib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Encorafenib Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Encorafenib Sales Market Share by Country (2020-2025)
Table 35. Americas Encorafenib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Encorafenib Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Encorafenib Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Encorafenib Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Encorafenib Sales Market Share by Region (2020-2025)
Table 40. APAC Encorafenib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Encorafenib Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Encorafenib Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Encorafenib Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Encorafenib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Encorafenib Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Encorafenib Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Encorafenib Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Encorafenib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Encorafenib Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Encorafenib Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Encorafenib
Table 52. Key Market Challenges & Risks of Encorafenib
Table 53. Key Industry Trends of Encorafenib
Table 54. Encorafenib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Encorafenib Distributors List
Table 57. Encorafenib Customer List
Table 58. Global Encorafenib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Encorafenib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Encorafenib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Encorafenib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Encorafenib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Encorafenib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Encorafenib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Encorafenib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Encorafenib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Encorafenib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Encorafenib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Encorafenib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Encorafenib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Encorafenib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Array BioPharma Basic Information, Encorafenib Manufacturing Base, Sales Area and Its Competitors
Table 73. Array BioPharma Encorafenib Product Portfolios and Specifications
Table 74. Array BioPharma Encorafenib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Array BioPharma Main Business
Table 76. Array BioPharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Encorafenib
Figure 2. Encorafenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encorafenib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Encorafenib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Encorafenib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Encorafenib Sales Market Share by Country/Region (2024)
Figure 10. Encorafenib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 50mg Capsules
Figure 12. Product Picture of 75mg Capsules
Figure 13. Global Encorafenib Sales Market Share by Type in 2025
Figure 14. Global Encorafenib Revenue Market Share by Type (2020-2025)
Figure 15. Encorafenib Consumed in Hospital
Figure 16. Global Encorafenib Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Encorafenib Consumed in Clinic
Figure 18. Global Encorafenib Market: Clinic (2020-2025) & (K Pcs)
Figure 19. Encorafenib Consumed in Pharmacy
Figure 20. Global Encorafenib Market: Pharmacy (2020-2025) & (K Pcs)
Figure 21. Encorafenib Consumed in Others
Figure 22. Global Encorafenib Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Encorafenib Sale Market Share by Application (2024)
Figure 24. Global Encorafenib Revenue Market Share by Application in 2025
Figure 25. Encorafenib Sales by Company in 2025 (K Pcs)
Figure 26. Global Encorafenib Sales Market Share by Company in 2025
Figure 27. Encorafenib Revenue by Company in 2025 ($ millions)
Figure 28. Global Encorafenib Revenue Market Share by Company in 2025
Figure 29. Global Encorafenib Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Encorafenib Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Encorafenib Sales 2020-2025 (K Pcs)
Figure 32. Americas Encorafenib Revenue 2020-2025 ($ millions)
Figure 33. APAC Encorafenib Sales 2020-2025 (K Pcs)
Figure 34. APAC Encorafenib Revenue 2020-2025 ($ millions)
Figure 35. Europe Encorafenib Sales 2020-2025 (K Pcs)
Figure 36. Europe Encorafenib Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Encorafenib Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Encorafenib Revenue 2020-2025 ($ millions)
Figure 39. Americas Encorafenib Sales Market Share by Country in 2025
Figure 40. Americas Encorafenib Revenue Market Share by Country (2020-2025)
Figure 41. Americas Encorafenib Sales Market Share by Type (2020-2025)
Figure 42. Americas Encorafenib Sales Market Share by Application (2020-2025)
Figure 43. United States Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Encorafenib Sales Market Share by Region in 2025
Figure 48. APAC Encorafenib Revenue Market Share by Region (2020-2025)
Figure 49. APAC Encorafenib Sales Market Share by Type (2020-2025)
Figure 50. APAC Encorafenib Sales Market Share by Application (2020-2025)
Figure 51. China Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 55. India Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Encorafenib Sales Market Share by Country in 2025
Figure 59. Europe Encorafenib Revenue Market Share by Country (2020-2025)
Figure 60. Europe Encorafenib Sales Market Share by Type (2020-2025)
Figure 61. Europe Encorafenib Sales Market Share by Application (2020-2025)
Figure 62. Germany Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 63. France Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Encorafenib Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Encorafenib Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Encorafenib Sales Market Share by Application (2020-2025)
Figure 70. Egypt Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Encorafenib Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Encorafenib in 2025
Figure 76. Manufacturing Process Analysis of Encorafenib
Figure 77. Industry Chain Structure of Encorafenib
Figure 78. Channels of Distribution
Figure 79. Global Encorafenib Sales Market Forecast by Region (2026-2031)
Figure 80. Global Encorafenib Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Encorafenib Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Encorafenib Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Encorafenib Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Encorafenib Revenue Market Share Forecast by Application (2026-2031)